About SLAM BioTherapeutics
SLAM BioTherapeutics is a private company based in Westlake Village, California, incorporated in 2022 in Delaware. It has reported $9,205,000 raised in three offerings on Form D since November 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | Dec 29, 2025 | $1,000,000of $4.0M target | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 20, 2025 | Mar 3, 2025 | $500,000of $10.0M target | 1 | $500K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 3, 2023 | Nov 13, 2023 | $7,705,000of $20.0M target | 38 | $202K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $9,205,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SLAM BioTherapeutics's Form D filed Dec 29, 2025.
RH
Richard Heinick
Executive Chairman and President
TS
Ted Schwartz
Director
SP
Steve Pazol
Director
MH
Mark Hagler
Director
DV
David Vennettilli
Director
Earlier filings also listed Theodore Schwartz (director, last listed Mar 2025) and Steve Potts (executive officer and director, last listed Mar 2025).